South and Central America Injectable Drug Delivery Market Analysis and Forecast by Size, Share, Growth, Trends 2031
South & Central America Injectable Drug Delivery Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Device Type [Conventional Drug Delivery Devices and Advanced Drug Delivery Devices (Prefilled Syringes, Pen Injectors, Auto-Injectors, Needle-Free Injectors, Wearable Injectors, and Other Advanced Types)], Formulation [Conventional Drug Delivery (Solutions, Reconstituted or Lyophilized formulations, Suspensions, and Emulsion), Novel Drug Delivery (Colloidal Dispersion, Microparticles, and Other Novel Drug Delivery), Long Acting Injectable Formulations], Formulation Packaging (Ampoules, Vials, Cartridges, and Bottles), Therapeutic Application (Diabetes, Oncology, Auto-Immune Disorders, Cardiovascular Diseases, Infectious Diseases, Pain Management, and Other Therapeutic Application), Route of Administration (Sub-cutaneous, Intramuscular, Intravenous, and Other Route of Administration), Usability (Disposable Injectors and Re-usable Injectors), and End User (Pharmaceutical and Biopharma Companies and CMOs and CDMOs)
- Status : Published
- Report Code : TIPRE00043699
- Category : Life Sciences
- No. of Pages : 281
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Executive Summary
1.1 Analyst Market Outlook
2. Global Injectable Drug Delivery Market Landscape
2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Forces Analysis
2.5Import–Export Analysis for Key Countries, HS Code 901831 (Syringes, with or without needles, used in medical, surgical, dental or veterinary sciences)
2.5.1Import Analysis for Key Countries
2.5.2Export Analysis for Key Countries
2.6Impact of Artificial Intelligence (AI)
2.7Product or Technology Roadmap
2.8Sustainability and ESG Trends
2.8.1Environmental Trends
2.8.2Social Trends
2.8.3Governance Trends
2.9Regulatory Framework
2.5 PEST Analysis
3. Competitive Landscape
3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2024 - By Key Players
3.3 Market Concentration
4. South and Central America Injectable Drug Delivery Market - Key Industry Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. Injectable Drug Delivery Market - South and Central America Analysis
5.1 South and Central America Injectable Drug Delivery Market Revenue (US$ Million), 2021 - 2031
5.2 South and Central America Injectable Drug Delivery Market Revenue Forecast and Analysis
6. South and Central America Injectable Drug Delivery Market Revenue Analysis - by Device Type
6.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by Device Type
6.1.1 Conventional Drug Delivery Devices
6.1.1.1 Overview
6.1.1.2 Conventional Drug Delivery Devices: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.1.2 Advanced Drug Delivery Devices
6.1.2.1 Overview
6.1.2.2 Advanced Drug Delivery Devices: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. South and Central America Injectable Drug Delivery Market Revenue Analysis - by Advanced Drug Delivery Devices By Device Type
7.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by Advanced Drug Delivery Devices By Device Type
7.1.1 Prefilled Syringes
7.1.1.1 Overview
7.1.1.2 Prefilled Syringes: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.1.2 Pen Injectors
7.1.2.1 Overview
7.1.2.2 Pen Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.1.3 Auto-Injectors
7.1.3.1 Overview
7.1.3.2 Auto-Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.1.4 Needle-Free Injectors
7.1.4.1 Overview
7.1.4.2 Needle-Free Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.1.5 Wearable Injectors
7.1.5.1 Overview
7.1.5.2 Wearable Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.1.6 Other Advanced Types
7.1.6.1 Overview
7.1.6.2 Other Advanced Types: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. South and Central America Injectable Drug Delivery Market Revenue Analysis - by Formulation
8.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by Formulation
8.1.1 Conventional Drug Delivery
8.1.1.1 Overview
8.1.1.2 Conventional Drug Delivery: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.1.2 Novel Drug Delivery
8.1.2.1 Overview
8.1.2.2 Novel Drug Delivery: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.1.3 Long Acting Injectable Formulations
8.1.3.1 Overview
8.1.3.2 Long Acting Injectable Formulations: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. South and Central America Injectable Drug Delivery Market Revenue Analysis - by Conventional Drug Delivery By Formulation
9.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by Conventional Drug Delivery By Formulation
9.1.1 Solutions
9.1.1.1 Overview
9.1.1.2 Solutions: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.1.2 Reconstituted or Lyophilized formulations
9.1.2.1 Overview
9.1.2.2 Reconstituted or Lyophilized formulations: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.1.3 Suspensions
9.1.3.1 Overview
9.1.3.2 Suspensions: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.1.4 Emulsion
9.1.4.1 Overview
9.1.4.2 Emulsion: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. South and Central America Injectable Drug Delivery Market Revenue Analysis - by Novel Drug Delivery By Formulation
10.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by Novel Drug Delivery By Formulation
10.1.1 Colloidal Dispersion
10.1.1.1 Overview
10.1.1.2 Colloidal Dispersion: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2 Microparticles
10.1.2.1 Overview
10.1.2.2 Microparticles: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.3 Other Novel Drug Delivery
10.1.3.1 Overview
10.1.3.2 Other Novel Drug Delivery: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. South and Central America Injectable Drug Delivery Market Revenue Analysis - by Formulation Packaging
11.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by Formulation Packaging
11.1.1 Ampoules
11.1.1.1 Overview
11.1.1.2 Ampoules: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2 Vials
11.1.2.1 Overview
11.1.2.2 Vials: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.3 Cartridges
11.1.3.1 Overview
11.1.3.2 Cartridges: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.4 Bottles
11.1.4.1 Overview
11.1.4.2 Bottles: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. South and Central America Injectable Drug Delivery Market Revenue Analysis - by Therapeutic Application
12.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by Therapeutic Application
12.1.1 Diabetes
12.1.1.1 Overview
12.1.1.2 Diabetes: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.1.2 Oncology
12.1.2.1 Overview
12.1.2.2 Oncology: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.1.3 Auto-Immune Disorders
12.1.3.1 Overview
12.1.3.2 Auto-Immune Disorders: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.1.4 Cardiovascular Diseases
12.1.4.1 Overview
12.1.4.2 Cardiovascular Diseases: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.1.5 Infectious Diseases
12.1.5.1 Overview
12.1.5.2 Infectious Diseases: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.1.6 Pain Management
12.1.6.1 Overview
12.1.6.2 Pain Management: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.1.7 Other Therapeutic Application
12.1.7.1 Overview
12.1.7.2 Other Therapeutic Application: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. South and Central America Injectable Drug Delivery Market Revenue Analysis - by Route Of Administration
13.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by Route Of Administration
13.1.1 Sub-cutaneous
13.1.1.1 Overview
13.1.1.2 Sub-cutaneous: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.2 Intramuscular
13.1.2.1 Overview
13.1.2.2 Intramuscular: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.3 Intravenous
13.1.3.1 Overview
13.1.3.2 Intravenous: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.4 Other Route of Administration
13.1.4.1 Overview
13.1.4.2 Other Route of Administration: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. South and Central America Injectable Drug Delivery Market Revenue Analysis - by Usability
14.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by Usability
14.1.1 Disposable Injectors
14.1.1.1 Overview
14.1.1.2 Disposable Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.1.2 Re-usable Injectors
14.1.2.1 Overview
14.1.2.2 Re-usable Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. South and Central America Injectable Drug Delivery Market Revenue Analysis - by End User
15.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis by End User
15.1.1 Pharmaceutical and Biopharma Companies
15.1.1.1 Overview
15.1.1.2 Pharmaceutical and Biopharma Companies: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2 CMOs and CDMOs
15.1.2.1 Overview
15.1.2.2 CMOs and CDMOs: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
16. South and Central America Injectable Drug Delivery Market - Country Analysis
16.1 South and Central America
16.1.1 South and Central America Injectable Drug Delivery Market Forecast and Analysis - by Country
16.1.1.1 Brazil Market
16.1.1.1.1 Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
16.1.1.1.2 Brazil: South and Central America Injectable Drug Delivery Market - By Segmentation
16.1.1.1.2.1 Device Type
16.1.1.1.2.2 Advanced Drug Delivery Devices By Device Type
16.1.1.1.2.3 Formulation
16.1.1.1.2.4 Conventional Drug Delivery By Formulation
16.1.1.1.2.5 Novel Drug Delivery By Formulation
16.1.1.1.2.6 Formulation Packaging
16.1.1.1.2.7 Therapeutic Application
16.1.1.1.2.8 Route Of Administration
16.1.1.1.2.9 Usability
16.1.1.1.2.10 End User
16.1.1.2 Argentina Market
16.1.1.2.1 Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
16.1.1.2.2 Argentina: South and Central America Injectable Drug Delivery Market - By Segmentation
16.1.1.2.2.1 Device Type
16.1.1.2.2.2 Advanced Drug Delivery Devices By Device Type
16.1.1.2.2.3 Formulation
16.1.1.2.2.4 Conventional Drug Delivery By Formulation
16.1.1.2.2.5 Novel Drug Delivery By Formulation
16.1.1.2.2.6 Formulation Packaging
16.1.1.2.2.7 Therapeutic Application
16.1.1.2.2.8 Route Of Administration
16.1.1.2.2.9 Usability
16.1.1.2.2.10 End User
16.1.1.3 Rest of South and Central America Market
16.1.1.3.1 Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
16.1.1.3.2 Rest of South and Central America: South and Central America Injectable Drug Delivery Market - By Segmentation
16.1.1.3.2.1 Device Type
16.1.1.3.2.2 Advanced Drug Delivery Devices By Device Type
16.1.1.3.2.3 Formulation
16.1.1.3.2.4 Conventional Drug Delivery By Formulation
16.1.1.3.2.5 Novel Drug Delivery By Formulation
16.1.1.3.2.6 Formulation Packaging
16.1.1.3.2.7 Therapeutic Application
16.1.1.3.2.8 Route Of Administration
16.1.1.3.2.9 Usability
16.1.1.3.2.10 End User
17 Injectable Drug Delivery Market Industry Landscape
18 - Key Company Profiles
18.1 B Braun SE
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Terumo Corp
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Cardinal Health Inc
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Phillips-Medisize
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Nipro Corp
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 Gerresheimer AG
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 West Pharmaceutical Services Inc
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Schott AG
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Becton Dickinson and Co
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Kindeva Drug Delivery LP
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments
19. Appendix
19.1 Glossary
19.2 Research Methodology and Approach
19.2.1 Secondary Research
19.2.2 Primary Research
19.2.3 Market Estimation Approach
19.2.3.1 Supply Side Analysis
19.2.3.2 Demand Side Analysis
19.2.4 Research Assumptions and Limitations
19.2.5 Currency Conversion
19.3 About The Insight Partners
19.4 Market Intelligence Cloud
List of Tables
Table 1. South and Central America Injectable Drug Delivery Market Segmentation
Table 3. List of Regulatory Bodies and Organizations
Table 4. Ease of Doing Business: Key Country Rankings
Table 5. Market Share Analysis, 2024 - By Key Players
Table 6. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 7. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device Type
Table 8. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
Table 9. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Formulation
Table 10. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Conventional Drug Delivery By Formulation
Table 11. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Novel Drug Delivery By Formulation
Table 12. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Formulation Packaging
Table 13. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Application
Table 14. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 15. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Usability
Table 16. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 18. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device Type
Table 19. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
Table 20. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Formulation
Table 21. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Conventional Drug Delivery By Formulation
Table 22. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Novel Drug Delivery By Formulation
Table 23. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Formulation Packaging
Table 24. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Application
Table 25. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 26. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Usability
Table 27. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device Type
Table 29. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
Table 30. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Formulation
Table 31. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Conventional Drug Delivery By Formulation
Table 32. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Novel Drug Delivery By Formulation
Table 33. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Formulation Packaging
Table 34. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Application
Table 35. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 36. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Usability
Table 37. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 38. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Device Type
Table 39. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
Table 40. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Formulation
Table 41. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Conventional Drug Delivery By Formulation
Table 42. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Novel Drug Delivery By Formulation
Table 43. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Formulation Packaging
Table 44. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Application
Table 45. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 46. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Usability
Table 47. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 48. Glossary - South and Central America Injectable Drug Delivery Market
List of Figures
Figure 1. South and Central America Injectable Drug Delivery Market - Value Chain Analysis
Figure 2. Porter's Five Forces Analysis
Figure 3. PEST Analysis
Figure 4. South and Central America Injectable Drug Delivery Market - Key Industry Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South and Central America Injectable Drug Delivery Market Revenue (US$ Million), 2021 - 2031
Figure 7. South and Central America Injectable Drug Delivery Market Share (%) - by Device Type, 2024 and 2031
Figure 8. Conventional Drug Delivery Devices: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Advanced Drug Delivery Devices: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. South and Central America Injectable Drug Delivery Market Share (%) - by Advanced Drug Delivery Devices By Device Type, 2024 and 2031
Figure 11. Prefilled Syringes: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Pen Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Auto-Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Needle-Free Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Wearable Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Other Advanced Types: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. South and Central America Injectable Drug Delivery Market Share (%) - by Formulation, 2024 and 2031
Figure 18. Conventional Drug Delivery: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Novel Drug Delivery: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Long Acting Injectable Formulations: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. South and Central America Injectable Drug Delivery Market Share (%) - by Conventional Drug Delivery By Formulation, 2024 and 2031
Figure 22. Solutions: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Reconstituted or Lyophilized formulations: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Suspensions: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Emulsion: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. South and Central America Injectable Drug Delivery Market Share (%) - by Novel Drug Delivery By Formulation, 2024 and 2031
Figure 27. Colloidal Dispersion: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Microparticles: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Other Novel Drug Delivery: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. South and Central America Injectable Drug Delivery Market Share (%) - by Formulation Packaging, 2024 and 2031
Figure 31. Ampoules: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Vials: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Cartridges: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Bottles: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. South and Central America Injectable Drug Delivery Market Share (%) - by Therapeutic Application, 2024 and 2031
Figure 36. Diabetes: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Oncology: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Auto-Immune Disorders: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Cardiovascular Diseases: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 40. Infectious Diseases: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Pain Management: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Other Therapeutic Application: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. South and Central America Injectable Drug Delivery Market Share (%) - by Route of Administration, 2024 and 2031
Figure 44. Sub-cutaneous: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Intramuscular: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Intravenous: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Other Route of Administration: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. South and Central America Injectable Drug Delivery Market Share (%) - by Usability, 2024 and 2031
Figure 49. Disposable Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Re-usable Injectors: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. South and Central America Injectable Drug Delivery Market Share (%) - by End User, 2024 and 2031
Figure 52. Pharmaceutical and Biopharma Companies: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. CMOs and CDMOs: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. South and Central America Injectable Drug Delivery Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 55. Brazil: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 56. Argentina: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 57. Rest of South and Central America: South and Central America Injectable Drug Delivery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 58. Bottom-Up Approach and Top-Down Approach
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For